A composition for wound healing and use thereof

Details for Australian Patent Application No. 2006258230 (hide)

Owner Chiang, C. Su, H. Wu, H. Shi, G.

Inventors Chiang, Chuan-Chi; Wu, Hua-Lin; Shi, Guey-Yueh; Su, Hui-Pin

Agent Spruson & Ferguson

Pub. Number AU-B-2006258230

PCT Pub. Number WO2006/135493

Priority 11/149,378 09.06.05 US; 11/361,560 24.02.06 US

Filing date 26 April 2006

Wipo publication date 21 December 2006

Acceptance publication date 24 December 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135493 Priority application(s): WO2006/135493

19 June 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read: FROM: Sui, GueyYueh TO: Shi, Guey-Yueh

18 September 2008 Assignment before Grant

  Blue Blood Biotech Corp. The application has been assigned to Chiang, Chuan-Chi; Su, Hui-Pin; Wu, Hua-Lin; Shi, Guey-Yueh

24 December 2009 Application Accepted

  Published as AU-B-2006258230

22 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258234-Aqueous crop protection formulations comprising asulam and synergistic herbicidal combinations thereof

2006258217-Oral pharmaceutical formulations comprising fenofibric acid and/or its salts